US Pharma MarketingRoche does $400M upfront, $15B deal with China
Roche pays $400M upfront in an ADC pact with Hansoh worth up to $15B, its sixth China deal since August. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in…
Roche is going all in on Chinese drug discovery and development.
The Swiss pharma has inked one of the largest cross-border collaborations of the year, promising $400 million upfront and potentially $15 billion in biobucks ...
Source: Endpoints News